Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPGB for Postdural Puncture Headache
NCT02365909Phase 1Terminated
- Sponsor
- University of Arkansas
- Start
- Jun 2015
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in post-dural puncture headache (PDPH) comparing Active (Bupivacaine) with Placebo (Saline) (2 arms). Primary endpoint: Headache verbal pain score at 1 hour. Started Jun 2015; status: terminated.
02
Drugs
bupivacaine
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on NCT02365909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02365909.